Industry / India
Pfizer India Triples Profit
February 2008 | Company News AlertBoosted by recent product launches, Pfizer India has revealed that net profit more than tripled for the year ending November 30 2007. Growth in turnover was also encouraging, rising by over 40% from the previous year. BMI expects the company to continue to perform well as uptake of its patented products increases.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
